Sigilon Therapeutics Inc. (NASDAQ: SGTX) is 225.71% higher on its value in year-to-date trading and has touched a low of $0.29 and a high of $1.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SGTX stock was last observed hovering at around $1.16 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $1.14, the stock is 14.78% and 54.91% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.6 million and changing -1.72% at the moment leaves the stock 75.16% off its SMA200. SGTX registered -11.63% loss for a year compared to 6-month loss of 66.74%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a 68.74% gain in the last 1 month and extending the period to 3 months gives it a 235.29%, and is -9.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 35.95% over the week and 23.62% over the month.
Sigilon Therapeutics Inc. (SGTX) has around 66 employees, a market worth around $43.75M and $12.30M in sales. Distance from 52-week low is 293.10% and -34.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-77.70%).
Sigilon Therapeutics Inc. (SGTX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Sigilon Therapeutics Inc. (SGTX) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 2.00, where 1 rate it as a Hold and 1 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
The EPS is expected to shrink by -39.80% this year
Sigilon Therapeutics Inc. (SGTX) Top Institutional Holders
The shares outstanding are 32.40M, and float is at 28.13M with Short Float at 0.87%.
Sigilon Therapeutics Inc. (SGTX) Insider Activity
A total of 0 insider transactions have happened at Sigilon Therapeutics Inc. (SGTX) in the last six months, with sales accounting for 0 and purchases happening 0 times.